Regenxbio (RGNX) Property, Plant & Equipment (Net) Growth (5y) (2020 - 2025)
Regenxbio (RGNX) Property, Plant & Equipment (Net) Growth (5y) (2020 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Regenxbio | 501.81 Mn | 271.74 Mn | 21.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 13.18% |
| Sep 30, 2025 | 22.57% |
| Jun 30, 2025 | 27.70% |
| Mar 31, 2025 | 30.36% |
| Dec 31, 2024 | 32.33% |
| Sep 30, 2024 | 33.63% |
| Jun 30, 2024 | 35.31% |
| Mar 31, 2024 | 40.71% |
| Dec 31, 2023 | 35.71% |
| Sep 30, 2023 | 46.84% |
| Jun 30, 2023 | 52.71% |
| Mar 31, 2023 | 57.03% |
| Dec 31, 2022 | 58.92% |
| Sep 30, 2022 | 64.92% |
| Jun 30, 2022 | 64.50% |
| Mar 31, 2022 | 65.00% |
| Dec 31, 2021 | 34.60% |
| Sep 30, 2021 | 83.95% |
| Jun 30, 2021 | 106.17% |
| Mar 31, 2021 | 132.04% |